Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Hueber
P148 JAK-inhibition by Baricitinib and Tofacitinib Ameliorates Pathological Bone Loss
OP0249 Multi-Biomarker Disease Activity and Autoantibody Status Lead to Cost Effective Tapering Algorithms in Rheumatoid Arthritis Patients in Sustained Remission
Related publications
958 Pharmacological Inhibition of JAK/STAT Signaling by Tofacitinib Prevents Organ Fibrosis: Novel Therapy for Scleroderma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Naringin Ameliorates Bone Loss Induced by Sciatic Neurectomy and Increases Semaphorin 3A Expression in Denervated Bone
Scientific Reports
Multidisciplinary
Inhibition of Bone Morphogenetic Protein 6 Receptors Ameliorates Sjögren’s Syndrome in Mice
Scientific Reports
Multidisciplinary
Effect of Janus Kinase Inhibition by Tofacitinib on Body Composition and Glucose Metabolism
Journal of Medical Investigation
Biochemistry
Medicine
Genetics
Molecular Biology
Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
Frontiers in Pharmacology
Pharmacology
Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
JAK Inhibition and Symptom Control in Myeloproliferative Neoplasms
Current Medical Research and Opinion
Medicine
Stemming Bone Loss by Suppressing Apoptosis
Journal of Clinical Investigation
Medicine
JAK Inhibition by Methotrexate (And csDMARDs) May Explain Clinical Efficacy as Monotherapy and Combination Therapy
Journal of Leukocyte Biology
Allergy
Immunology
Cell Biology
